Episode 668: Episode 26-11 A Breakthrough Treatment for Spinal Cord Injuries???
TechNation Radio PodcastShow Notes
On this week’s Tech Nation, Moira speaks with Dr. Adam Rogers of NervGen Pharma about a new treatment in development that’s seeing significant trial results for patients with spinal cord injuries. Then, does that look on your pet’s face mean what you think it means? Jay Ingram joins Moira to talk about “The Science of Pets” and what it has to do with humans.
On this week’s BioTech Nation, Moira speaks with Dr. Adam Rogers, CEO of NervGen Pharma, about a new treatment that’s showing significant trial results for patients with spinal cord injuries. While typically, patient progress is defined by the early months of recovery after the injury, trial participants are seeing increased function as much as 10 years post-trauma.
More from TechNation Radio Podcast
On this week’s Tech Nation, Moira speaks with Author Dan Roam about creativity in the AI age, and what generative AI can really do (and not do!). Then, Dan tells us about his latest visual storytelling project, a poster titled “The Blueprint: How SpaceX Plans to Colonize the Cosmos in the next 100 Years.”
On this week’s Tech Nation, Moira speaks with Stanford Professor of Epidemiology & Population Health, Dr. Michelle Williams, about the history of public health in the United States and how it’s shaped modern society. She says public health is all of our business, and shares more from her book, “The Cure for Everything: The Epic Struggle for Public Health and a Radical Vision for Human Thriving”. Then, Heather Turner of LB Pharmaceuticals joins to discuss a drug that’s in trials in the US, but already used by several million patients in Europe for Schizophrenia and other neuropsychiatric conditions. We delve into why the drug couldn’t go straight to approval here, and how they’re working on it.
On this week’s Tech Nation, Moira speaks with Dr Shana Kelley, President of Bioengineering and Head of Biohub Chicago, about AI-Powered Biology - what is it? And what could it mean for the future of research? Then, Dr Harry Selker and Dr Atul Deshpande of Immediate Therapeutics tell us how they’ve come up with a speedy intervention for heart attacks. And, what exactly differentiates the NIH, the FDA, and the CDC? We take a closer look at that, and what they have in common.
On this week’s Tech Nation, Moira speaks with Pediatric surgeon Dr. Dana Suskind about her book, “Human Raised: Nurturing Connection, Curiosity & Lifelong Learning in the Age of AI”, and navigating the unique challenge AI presents for parents. Then, FUJIFILM Biotechnologies Chairman Toshi Iida joins to share how the company has gone way beyond film into the biotech landscape. And, do you ever feel like a virtual meeting isn’t going quite how you expected? Dr. Andrew Brodsky breaks down the science behind virtual communication.
On this week’s Tech Nation, Moira speaks with Dr. Richard Elwes about his book, “Huge Numbers: A Story of Counting Ambitiously, from 4 ½ to Fish 7”. They discuss what really makes a number “huge,” and how the way we count numbers is intertwined with the way we make sense of the world around us. Then, Founder, President, & CEO Lew Bender shares how Intensity Therapeutics is working to change how chemotherapy is administered to patients, with the hopes of reducing the toll it takes on the body.